This is not a covid stock my friend. The core business of this stock is HIV and OEM supplier. Covid was/is purely a complementary market for their OEM devices to transition into. Keep your eyes on the revenue generated through the OEM side of the business in the next quarterly. This will be an indication as to level of market demand out there for their testing kits.
